1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Alzheimer's Disease Treatments Revenue 1.4 Market Analysis by Type 1.4.1 Global Alzheimer's Disease Treatments Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Cholinesterase Inhibitors 1.4.3 NMDA Antagonists 1.5 Market by Application 1.5.1 Global Alzheimer's Disease Treatments Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Diagnostic Laboratories 1.5.4 Research and Academic Laboratories 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Alzheimer's Disease Treatments Industry Impact 1.6.1 How the Covid-19 is Affecting the Alzheimer's Disease Treatments Industry 1.6.1.1 Alzheimer's Disease Treatments Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Alzheimer's Disease Treatments Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Alzheimer's Disease Treatments Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Alzheimer's Disease Treatments Market Perspective (2015-2026) 2.2 Alzheimer's Disease Treatments Growth Trends by Regions 2.2.1 Alzheimer's Disease Treatments Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Alzheimer's Disease Treatments Historic Market Share by Regions (2015-2020) 2.2.3 Alzheimer's Disease Treatments Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Alzheimer's Disease Treatments Market Growth Strategy 2.3.6 Primary Interviews with Key Alzheimer's Disease Treatments Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Alzheimer's Disease Treatments Players by Market Size 3.1.1 Global Top Alzheimer's Disease Treatments Players by Revenue (2015-2020) 3.1.2 Global Alzheimer's Disease Treatments Revenue Market Share by Players (2015-2020) 3.1.3 Global Alzheimer's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Alzheimer's Disease Treatments Market Concentration Ratio 3.2.1 Global Alzheimer's Disease Treatments Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Treatments Revenue in 2019 3.3 Alzheimer's Disease Treatments Key Players Head office and Area Served 3.4 Key Players Alzheimer's Disease Treatments Product Solution and Service 3.5 Date of Enter into Alzheimer's Disease Treatments Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Alzheimer's Disease Treatments Historic Market Size by Type (2015-2020) 4.2 Global Alzheimer's Disease Treatments Forecasted Market Size by Type (2021-2026) 5 Alzheimer's Disease Treatments Breakdown Data by Application (2015-2026) 5.1 Global Alzheimer's Disease Treatments Market Size by Application (2015-2020) 5.2 Global Alzheimer's Disease Treatments Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Alzheimer's Disease Treatments Market Size (2015-2020) 6.2 Alzheimer's Disease Treatments Key Players in North America (2019-2020) 6.3 North America Alzheimer's Disease Treatments Market Size by Type (2015-2020) 6.4 North America Alzheimer's Disease Treatments Market Size by Application (2015-2020) 7 Europe 7.1 Europe Alzheimer's Disease Treatments Market Size (2015-2020) 7.2 Alzheimer's Disease Treatments Key Players in Europe (2019-2020) 7.3 Europe Alzheimer's Disease Treatments Market Size by Type (2015-2020) 7.4 Europe Alzheimer's Disease Treatments Market Size by Application (2015-2020) 8 China 8.1 China Alzheimer's Disease Treatments Market Size (2015-2020) 8.2 Alzheimer's Disease Treatments Key Players in China (2019-2020) 8.3 China Alzheimer's Disease Treatments Market Size by Type (2015-2020) 8.4 China Alzheimer's Disease Treatments Market Size by Application (2015-2020) 9 Japan 9.1 Japan Alzheimer's Disease Treatments Market Size (2015-2020) 9.2 Alzheimer's Disease Treatments Key Players in Japan (2019-2020) 9.3 Japan Alzheimer's Disease Treatments Market Size by Type (2015-2020) 9.4 Japan Alzheimer's Disease Treatments Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Alzheimer's Disease Treatments Market Size (2015-2020) 10.2 Alzheimer's Disease Treatments Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Alzheimer's Disease Treatments Market Size by Type (2015-2020) 10.4 Southeast Asia Alzheimer's Disease Treatments Market Size by Application (2015-2020) 11 India 11.1 India Alzheimer's Disease Treatments Market Size (2015-2020) 11.2 Alzheimer's Disease Treatments Key Players in India (2019-2020) 11.3 India Alzheimer's Disease Treatments Market Size by Type (2015-2020) 11.4 India Alzheimer's Disease Treatments Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Alzheimer's Disease Treatments Market Size (2015-2020) 12.2 Alzheimer's Disease Treatments Key Players in Central & South America (2019-2020) 12.3 Central & South America Alzheimer's Disease Treatments Market Size by Type (2015-2020) 12.4 Central & South America Alzheimer's Disease Treatments Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Eisai 13.1.1 Eisai Company Details 13.1.2 Eisai Business Overview and Its Total Revenue 13.1.3 Eisai Alzheimer's Disease Treatments Introduction 13.1.4 Eisai Revenue in Alzheimer's Disease Treatments Business (2015-2020)) 13.1.5 Eisai Recent Development 13.2 Forest Laboratories 13.2.1 Forest Laboratories Company Details 13.2.2 Forest Laboratories Business Overview and Its Total Revenue 13.2.3 Forest Laboratories Alzheimer's Disease Treatments Introduction 13.2.4 Forest Laboratories Revenue in Alzheimer's Disease Treatments Business (2015-2020) 13.2.5 Forest Laboratories Recent Development 13.3 H. Lundbeck 13.3.1 H. Lundbeck Company Details 13.3.2 H. Lundbeck Business Overview and Its Total Revenue 13.3.3 H. Lundbeck Alzheimer's Disease Treatments Introduction 13.3.4 H. Lundbeck Revenue in Alzheimer's Disease Treatments Business (2015-2020) 13.3.5 H. Lundbeck Recent Development 13.4 Johnson and Johnson 13.4.1 Johnson and Johnson Company Details 13.4.2 Johnson and Johnson Business Overview and Its Total Revenue 13.4.3 Johnson and Johnson Alzheimer's Disease Treatments Introduction 13.4.4 Johnson and Johnson Revenue in Alzheimer's Disease Treatments Business (2015-2020) 13.4.5 Johnson and Johnson Recent Development 13.5 Merz Pharma 13.5.1 Merz Pharma Company Details 13.5.2 Merz Pharma Business Overview and Its Total Revenue 13.5.3 Merz Pharma Alzheimer's Disease Treatments Introduction 13.5.4 Merz Pharma Revenue in Alzheimer's Disease Treatments Business (2015-2020) 13.5.5 Merz Pharma Recent Development 13.6 Novartis 13.6.1 Novartis Company Details 13.6.2 Novartis Business Overview and Its Total Revenue 13.6.3 Novartis Alzheimer's Disease Treatments Introduction 13.6.4 Novartis Revenue in Alzheimer's Disease Treatments Business (2015-2020) 13.6.5 Novartis Recent Development 13.7 Pfizer 13.7.1 Pfizer Company Details 13.7.2 Pfizer Business Overview and Its Total Revenue 13.7.3 Pfizer Alzheimer's Disease Treatments Introduction 13.7.4 Pfizer Revenue in Alzheimer's Disease Treatments Business (2015-2020) 13.7.5 Pfizer Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Alzheimer's Disease Treatments Key Market Segments Table 2. Key Players Covered: Ranking by Alzheimer's Disease Treatments Revenue Table 3. Ranking of Global Top Alzheimer's Disease Treatments Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Alzheimer's Disease Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Cholinesterase Inhibitors Table 6. Key Players of NMDA Antagonists Table 7. COVID-19 Impact Global Market: (Four Alzheimer's Disease Treatments Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Alzheimer's Disease Treatments Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Alzheimer's Disease Treatments Players to Combat Covid-19 Impact Table 12. Global Alzheimer's Disease Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Alzheimer's Disease Treatments Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Alzheimer's Disease Treatments Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Alzheimer's Disease Treatments Market Share by Regions (2015-2020) Table 16. Global Alzheimer's Disease Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Alzheimer's Disease Treatments Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Alzheimer's Disease Treatments Market Growth Strategy Table 22. Main Points Interviewed from Key Alzheimer's Disease Treatments Players Table 23. Global Alzheimer's Disease Treatments Revenue by Players (2015-2020) (Million US$) Table 24. Global Alzheimer's Disease Treatments Market Share by Players (2015-2020) Table 25. Global Top Alzheimer's Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Treatments as of 2019) Table 26. Global Alzheimer's Disease Treatments by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Alzheimer's Disease Treatments Product Solution and Service Table 29. Date of Enter into Alzheimer's Disease Treatments Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 32. Global Alzheimer's Disease Treatments Market Size Share by Type (2015-2020) Table 33. Global Alzheimer's Disease Treatments Revenue Market Share by Type (2021-2026) Table 34. Global Alzheimer's Disease Treatments Market Size Share by Application (2015-2020) Table 35. Global Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 36. Global Alzheimer's Disease Treatments Market Size Share by Application (2021-2026) Table 37. North America Key Players Alzheimer's Disease Treatments Revenue (2019-2020) (Million US$) Table 38. North America Key Players Alzheimer's Disease Treatments Market Share (2019-2020) Table 39. North America Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 40. North America Alzheimer's Disease Treatments Market Share by Type (2015-2020) Table 41. North America Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 42. North America Alzheimer's Disease Treatments Market Share by Application (2015-2020) Table 43. Europe Key Players Alzheimer's Disease Treatments Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Alzheimer's Disease Treatments Market Share (2019-2020) Table 45. Europe Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 46. Europe Alzheimer's Disease Treatments Market Share by Type (2015-2020) Table 47. Europe Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 48. Europe Alzheimer's Disease Treatments Market Share by Application (2015-2020) Table 49. China Key Players Alzheimer's Disease Treatments Revenue (2019-2020) (Million US$) Table 50. China Key Players Alzheimer's Disease Treatments Market Share (2019-2020) Table 51. China Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 52. China Alzheimer's Disease Treatments Market Share by Type (2015-2020) Table 53. China Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 54. China Alzheimer's Disease Treatments Market Share by Application (2015-2020) Table 55. Japan Key Players Alzheimer's Disease Treatments Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Alzheimer's Disease Treatments Market Share (2019-2020) Table 57. Japan Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 58. Japan Alzheimer's Disease Treatments Market Share by Type (2015-2020) Table 59. Japan Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 60. Japan Alzheimer's Disease Treatments Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Alzheimer's Disease Treatments Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Alzheimer's Disease Treatments Market Share (2019-2020) Table 63. Southeast Asia Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Alzheimer's Disease Treatments Market Share by Type (2015-2020) Table 65. Southeast Asia Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Alzheimer's Disease Treatments Market Share by Application (2015-2020) Table 67. India Key Players Alzheimer's Disease Treatments Revenue (2019-2020) (Million US$) Table 68. India Key Players Alzheimer's Disease Treatments Market Share (2019-2020) Table 69. India Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 70. India Alzheimer's Disease Treatments Market Share by Type (2015-2020) Table 71. India Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 72. India Alzheimer's Disease Treatments Market Share by Application (2015-2020) Table 73. Central & South America Key Players Alzheimer's Disease Treatments Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Alzheimer's Disease Treatments Market Share (2019-2020) Table 75. Central & South America Alzheimer's Disease Treatments Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Alzheimer's Disease Treatments Market Share by Type (2015-2020) Table 77. Central & South America Alzheimer's Disease Treatments Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Alzheimer's Disease Treatments Market Share by Application (2015-2020) Table 79. Eisai Company Details Table 80. Eisai Business Overview Table 81. Eisai Product Table 82. Eisai Revenue in Alzheimer's Disease Treatments Business (2015-2020) (Million US$) Table 83. Eisai Recent Development Table 84. Forest Laboratories Company Details Table 85. Forest Laboratories Business Overview Table 86. Forest Laboratories Product Table 87. Forest Laboratories Revenue in Alzheimer's Disease Treatments Business (2015-2020) (Million US$) Table 88. Forest Laboratories Recent Development Table 89. H. Lundbeck Company Details Table 90. H. Lundbeck Business Overview Table 91. H. Lundbeck Product Table 92. H. Lundbeck Revenue in Alzheimer's Disease Treatments Business (2015-2020) (Million US$) Table 93. H. Lundbeck Recent Development Table 94. Johnson and Johnson Company Details Table 95. Johnson and Johnson Business Overview Table 96. Johnson and Johnson Product Table 97. Johnson and Johnson Revenue in Alzheimer's Disease Treatments Business (2015-2020) (Million US$) Table 98. Johnson and Johnson Recent Development Table 99. Merz Pharma Company Details Table 100. Merz Pharma Business Overview Table 101. Merz Pharma Product Table 102. Merz Pharma Revenue in Alzheimer's Disease Treatments Business (2015-2020) (Million US$) Table 103. Merz Pharma Recent Development Table 104. Novartis Company Details Table 105. Novartis Business Overview Table 106. Novartis Product Table 107. Novartis Revenue in Alzheimer's Disease Treatments Business (2015-2020) (Million US$) Table 108. Novartis Recent Development Table 109. Pfizer Company Details Table 110. Pfizer Business Overview Table 111. Pfizer Product Table 112. Pfizer Revenue in Alzheimer's Disease Treatments Business (2015-2020) (Million US$) Table 113. Pfizer Recent Development Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Alzheimer's Disease Treatments Market Share by Type: 2020 VS 2026 Figure 2. Cholinesterase Inhibitors Features Figure 3. NMDA Antagonists Features Figure 4. Global Alzheimer's Disease Treatments Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Diagnostic Laboratories Case Studies Figure 7. Research and Academic Laboratories Case Studies Figure 8. Others Case Studies Figure 9. Alzheimer's Disease Treatments Report Years Considered Figure 10. Global Alzheimer's Disease Treatments Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Alzheimer's Disease Treatments Market Share by Regions: 2020 VS 2026 Figure 12. Global Alzheimer's Disease Treatments Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Alzheimer's Disease Treatments Market Share by Players in 2019 Figure 15. Global Top Alzheimer's Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Treatments as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Alzheimer's Disease Treatments Revenue in 2019 Figure 17. North America Alzheimer's Disease Treatments Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Alzheimer's Disease Treatments Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Alzheimer's Disease Treatments Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Alzheimer's Disease Treatments Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Alzheimer's Disease Treatments Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Alzheimer's Disease Treatments Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Alzheimer's Disease Treatments Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Eisai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Eisai Revenue Growth Rate in Alzheimer's Disease Treatments Business (2015-2020) Figure 26. Forest Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Forest Laboratories Revenue Growth Rate in Alzheimer's Disease Treatments Business (2015-2020) Figure 28. H. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. H. Lundbeck Revenue Growth Rate in Alzheimer's Disease Treatments Business (2015-2020) Figure 30. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Johnson and Johnson Revenue Growth Rate in Alzheimer's Disease Treatments Business (2015-2020) Figure 32. Merz Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Merz Pharma Revenue Growth Rate in Alzheimer's Disease Treatments Business (2015-2020) Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Novartis Revenue Growth Rate in Alzheimer's Disease Treatments Business (2015-2020) Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Pfizer Revenue Growth Rate in Alzheimer's Disease Treatments Business (2015-2020) Figure 38. Bottom-up and Top-down Approaches for This Report Figure 39. Data Triangulation Figure 40. Key Executives Interviewed

Eisai Forest Laboratories H. Lundbeck Johnson and Johnson Merz Pharma Novartis Pfizer